Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03840863 · ClinicalTrials.gov registry record · NA
Effects of Chronic Energy Drink Consumption on Cardiometabolic Endpoints
A NA study, sponsored by University of the Pacific.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT03840863: Completed NA study, sponsored by University of the Pacific.
NCT03840863 is a NA study that has completed, run by University of the Pacific. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03840863, a NA study, has completed, sponsored by University of the Pacific.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
Many people use energy drinks (EDs) regularly, but the overall health concerns are still unknown. There are many energy drink products that contain a mixture of caffeine and other energy-boosting ingredients and supplements which can affect parameters related to the heart, blood pressure and blood glucose. Several previous studies have shown that energy drinks may affect heart rhythm and blood pressure significantly. As energy drinks are sugar-sweetened beverages, long-term use may also affect the body's metabolism, including cholesterol, blood sugars, and weight. The purpose of this study is to learn if drinking energy drinks everyday may affect a person's cardiometabolic health.
Primary Outcome
Measuring acute changes in peripheral systolic blood pressure before and 1 hour after energy drink consumption
Interventions
- DIETARY_SUPPLEMENT Commercially-Available Energy Drink
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2019-03-06 |
| Est. Completion | 2020-07-30 |
| Phase | NA |
What the finished NCT03840863 record still lists
NCT03840863 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Commercially-Available Energy Drink is the first listed.
NCT03840863 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03840863 about?
NCT03840863 is a clinical study titled "Effects of Chronic Energy Drink Consumption on Cardiometabolic Endpoints". Many people use energy drinks (EDs) regularly, but the overall health concerns are still unknown. There are many energy drink products that contain a mixture of caffeine and other energy-boosting ingredients and supplements which can affect parameters related to the heart, blood pressure and blood g...
What is the current status of trial NCT03840863?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2019-03-06. Estimated completion is 2020-07-30.
What interventions are being tested in trial NCT03840863?
The interventions under investigation include: Commercially-Available Energy Drink (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03840863?
This trial is sponsored by University of the Pacific, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03840863's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI